~~<i id='F35DC80645'><strike id='F35DC80645'><tt id='F35DC80645'><pre id='F35DC80645'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

leisure time

author：Wikipedia 2025-10-02 13:14:43 - browse：65

A green number 3 with an eye is surrounded by smaller, black number 3s on a purple background — 3 to watch coverage from STAT — Christine Kao/STAT

Life in the CRISPR lane tends to move at lightning speed. This year saw the first-ever approval of a medicine based on the gene editing technology, barely more than a decade after publication of its first demonstration by Nobel laureates Jennifer Doudna and Emmanuelle Charpentier.

The landmark decision paves the way for in vivo therapies, which edit cells inside the body, to reach patients, as well as treatments based on more efficient genome editors with fancier DNA-altering tricks up their sleeves.

Here are three CRISPR developments we’re watching in 2024:

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Does good food count as health care? Study aims to find out

hotspot

knowledge

focus

hotspot

knowledge

focus

AlexHogan/STATYou’rereadingthewebeditionofSTATHealthTech,ourguidetohowtechistransformingthelifescien

WSS

Physician groups backed by private equity giant lobby on mergers

World's first CRISPR

David Sabatini, ex

No plane should take off without an EpiPen onboard

Tire on Delta flight pops while landing in Atlanta, 1 person injured, airline says

A daunting task: navigating dual Medicare, Medicaid eligibility

explore

leisure time

hotspot

Dobbs anniversary: the lost opportunity of abortion as health care

National panel will explore requiring free Covid tests

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Scientists inch closer to single

DIEP, the 'gold standard' of breast reconstruction, is under threat

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

Hepatitis C has a cure — but many Americans still lack access to it

David Sabatini, ex

Trump demands the U.S. pay no more for drugs than other countries … again

Hospitals look to new technology to keep health care workers safe

knowledge

Pence says 'crackpot lawyers' told Trump what he wanted to hear

Childhood cancer progress stalls for Black, Hispanic kids: Report

5 important ways Henrietta Lacks changed medical science

Vertex non

Weight loss drug costs may need more research, senator suggests

Infectious disease expert Jeanne Marrazzo assumes Fauci role

focus

hotspot

knowledge

focus